CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX [Phase 3]
Summary
Phase 3 trial update evaluating short-term SIMDAX for acute decompensated heart failure; status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Acute Decompensated Heart Failure | Phase 3 | Status: UNKNOWN